OYOzkan Yetkin

Ozkan Yetkin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ozkan Yetkin has a total of 40 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Pandoraea spp. infection in the course of post-COVID pulmonary fibrosis: a rare case report

    by Ahmet Yurttaş, Fatma İrEm Sevimliler, Deniz Çelik, Hüseyin Lakadamyalı, Özkan Yetkin

    Pandoraea species are rare, Gram-negative, aerobic bacilli classified in the Burkholderiaceae family. They are increasingly recognized as pathogens in both cystic fibrosis (CF) and non-CF patients, frequently associated with chronic pulmonary infections and multidrug resistance. These organisms can cause significant inflammatory responses and exacerbate pre-existing structural lung diseases. Case: A 32-year-old female with a history of allergic asthma presented with had worsening cough, shortness of breath, and fatigue following a COVID-19 infection. Chest computed tomography revealed bilateral fibrotic changes and cystic bronchiectasis, in addition to nodular lesions predominantly in the upper lobes. Bronchoscopy and bronchoalveolar lavage (BAL) were performed. In BAL culture, Pandoraea spp. exhibiting sensitivity to amikacin, cefepime, ciprofloxacin, gentamicin, piperacillin, aztreonam, and imipenem were identified. The patient was treated with ciprofloxacin for a month, resulting in significant clinical and radiological improvement and a reduction in inflammatory markers. Post-COVID pulmonary fibrosis can facilitate the proliferation of opportunistic bacterial infections. Pandoraea species can exacerbate chronic lung damage and inflammation thru biofilm formation and the induction of pro-inflammatory cytokines (IL-6, IL-8). This case highlights the importance of considering Pandoraea spp. as a potential cause of unresolved pulmonary infections, particularly in patients with pre-existing viral lung damage or bronchiectasis. Although rare, Pandoraea infections can complicate post-COVID pulmonary pathology and mimic chronic infection processes. Early microbiological identification and appropriate antimicrobial therapy are crucial for optimal patient outcomes.

  • Open Access

    The Influence of COPD Awareness on Hospital Admissions: A Paradoxical Relationship?

    by Deniz Çelik, Murat Yıldız, Oral Menteş, Özkan Yetkin, Hüseyin Lakadamyalı, Savaş Gegin, Ahmet Yurttaş, Maşide Arı, Derya Kızılgöz, Kerem Ensarioğlu, et al.

    Background: Chronic obstructive pulmonary disease (COPD) is a progressive respiratory condition characterised by frequent exacerbations, which contribute to increased healthcare utilisation and reduced quality of life. Knowledge about the disease is generally associated with better outcomes. This study examined the association between COPD knowledge levels and healthcare utilisation (including hospital readmissions) in patients hospitalised for acute exacerbations. Methods: This prospective observational study included 78 patients hospitalised for COPD exacerbations and classified as Group D according to the updated GOLD criteria 2021. The Bristol COPD Knowledge Questionnaire (BCKQ) was administered prior to discharge to evaluate patients’ knowledge levels. Data were collected about emergency department visits, hospitalisations, and intensive care unit (ICU) admissions for a six-month follow-up period. Statistical analyses assessed the relationships between BCKQ scores, patient outcomes, and risk factors influencing hospital readmissions. Results: The median BCKQ total score was 23 (6–40). A strong correlation was found between higher BCKQ scores and more visits to the emergency room (p = 0.005), especially in the subdomains of epidemiology (p = 0.010), aetiology (p = 0.033), and dyspnoea (p = 0.042). Higher antibiotic knowledge scores were associated with ICU admissions (p = 0.019). Logistic regression analysis revealed that domiciliary NIV use (OR = 2.60, p = 0.041) and higher BCKQ scores (OR = 1.10, p = 0.010) were significant predictors of hospital readmissions. However, no significant relationship was found between survival and BCKQ or mCCI scores (p > 0.05). Conclusions: This study indicates that while increased COPD knowledge is associated with greater healthcare utilisation, it does not directly translate into improved clinical outcomes. These findings underscore the importance of integrating practical skills and behaviour management into educational programmes to help patients effectively apply their knowledge. Further research is needed to explore long-term implications and strategies to optimise knowledge-based interventions.


  • Open Access

    An obstructive retrosternal thyroid mass mimicking asthma

    by Büşra Güngör, Deniz Çelik, Ahmet Yurttaş, Ezgi Akkuş, Özkan Yetkin, Hüseyin Lakadamyalı

    The term retrosternal/intrathoracic goiter was first defined by Haller in 1749. It is usually located in the anterior mediastinum. When it reaches large sizes, it can cause various pressure symptoms. Respiratory distress may occur due to tracheal compression, difficulty swallowing due to esophageal compression, and venous fullness findings may occur as a result of pressure on vascular structures. Although rare, it can be life-threatening; It may also cause respiratory failure, which may develop as a result of sudden growth that may occur secondary to intrathyroidal hemorrhage or cystic degeneration. In this case, we aimed to present a patient who experienced respiratory distress due to a thyroid mass extending retrosternally and causing tracheal compression, and whose complaints did not go away despite optimum asthma treatment.


  • Open Access

    Management of pulmonary tuberculosis and hypersensitivity reaction to antituberculosis drugs in a patient presenting with recurrent psoas abscess

    by Ahmet Yurttaş, Elif Büşra Öbek, Deniz Çelik, Özkan Yetkin, Hüseyin Lakadamyalı

    Psoas abscess is a difficult disease to diagnose. MTB can cause psoas abscess. First generation anti-TB drugs are used in the treatment of TB, side effects may occur during treatment; one of these side effects is hypersensitivity reactions. In this case report, we aimed to present a patient who presented with recurrent psoas abscess occurs after pulmonary tuberculosis and developed hypersensitivity reaction to antituberculosis drugs and the treatment method we applied. A 44-year-old male patient presented with fever, cough and right flank pain. It was learned that he had hypothyroidism and received antibiotherapy and drainage treatment for recurrent psoas abscesses. His family history was unremarkable and respiratory sounds were normal. Fever was 37.8 °C. WBC: 6.640/mm³, CRP: 70mg/L, ESR: 33mm/h. Liver dynamic CT showed psoas abscess, drainage was provided.Pulmonary tuberculosis was thought to be the etiology of recurrent psoas abscess, thorax CT was ordered and culture and aside resitant staining (ARS) were sent from sputum and abscess upon observation of infiltrations.(Figure 1) No growth was observed in abscess culture and MTB was not detected. With the initiation of HRZE treatment, the patient developed sudden dyspnea, high fever, and skin rashes, and the treatment was terminated. Premedication was decided to be performed before the drug and progressive drug loading was performed to determine the responsible drug. The patient, who had no new allergic reaction during the treatment period, was discharged and methylprednisolone tablets were prescribed for 21 days, bilastine and desloratadine tablets were prescribed for 6 months together with TB drugs. Tuberculosis is among the important causes of morbidity and mortality in developing countries. At the beginning of treatment, patients should be told about the side effects that may occur with the drugs they use. In patients who develop hypersensitivity reactions, temporary or permanent discontinuation of drugs and often hospitalization of the patient is required. Antihistamines and steroids may need to be used for the control of severe reactions.In our case, we wanted to emphasize that patients may develop tuberculosis even if they do not present with pulmonary symptoms and that drug side effects should always be kept in mind and the necessity and importance of premedication and gradual drug loading therapy in patients with hypersensitivity reactions.

  • Open Access

    Treatment of recurrent pulmonary thromboembolism with ecosonic endovascular system

    by Elif Büşra Öbek, Deniz Çelik, Ezgi Akkuş, Özgür Akkaya, Özkan Yetkin, Hüseyin Lakadamyalı

    Venous thromboembolism is a collective term that describes two diseases, pulmonary thromboembolism (PTE) and deep vein thrombosis, with or without symptoms but often accompanying each other. Pulmonary thromboembolism (PTE) develops in most cases due to thrombus formation in the deep veins of the lower extremities and migrates to the pulmonary artery and/or its branches. It is a preventable disease with high mortality and morbidity and includes diagnostic difficulties. Recurrence may occur despite treatment in 5-23% of PTE cases. Patients may apply to the hospital with symptoms such as unexplained dyspnea, stabbing or atypical chest pain, hemoptysis, and syncope. We aimed to present the patient who had chronic deep vein thrombosis (DVT) and was frequently hospitalized due to recurrent massive PTE. In our case, disease status requires catheter thrombolytic therapies two times in three months.

  • Open Access

    Alveolitis as a result of dust chlorine exposure

    by Hüseyin Türkdağlı, Deniz Çelik, Hüseyin Lakadamyalı, Özkan Yetkin

    Hypersensitivity pneumonia of the lung, also called "extrinsic allergic alveolitis" or "hypersensitivity pneumonitis", is a condition in which the lung tissue becomes inflamed for reasons other than microbial causes. There may be many different reasons. Among the most common reasons were bird feeding, agricultural works and air conditioners. There are acute, subacute or chronic (slowly progressing) forms. Acute and subacute forms may recur, while the chronic form progresses and causes permanent and irreversible damage such as fibrosis and emphysema. Bird proteins, mammalian proteins, fungi, bacterial proteins and small molecular weight chemicals are generally blamed for the formation of the disease. Sometimes the causative agent may not be identified. In this case, we aimed to present a patient who applied to our clinic due to complaints of sudden respiratory distress, rapid fatigue and cough as a result of dust chlorine exposure, and was diagnosed with alveolitis, hospitalized and followed up.

  • Open Access

    Photodermatit developed with pirfenidone treatment in patient diagnosed with IPF

    by Ezgi Akkuş, Deniz Çelik, Özkan Yetkin, Hüseyin Lakadamyalı

    Idiopathic pulmonary fibrosis (IPF) is the most common of the major idiopathic interstitial pneumonia (IIP) of unknown etiology, often presenting in advanced age, limited to the lungs, characterized by histopathologically and/or radiologically usual interstitial pneumonia (UIP) pattern, and progressing with chronic, progressive fibrosis. is the most common form. Since IPF is a disease with irreversible fibrosis, there is no curative treatment except lung transplantation. The aim of the treatments given is to stop the progression of the disease, to prevent exacerbations and to prolong the survival time. The greatest improvement in the treatment of IPF in recent years has been the use of antifibrotic drugs (Pirfenidone and nintedanib) that prevent fibrosis developing in the lung parenchyma. In this case, we aimed to present the side effect of photodermatitis in a patient who applied to our outpatient clinic with complaints of shortness of breath and cough for many years and was diagnosed with IPF and started on pirfenidone treatment.


  • The effects of PAP therapy on energy metabolism in patients with obstructive sleep apnea syndrome

    by Ayşegül ALTINTOP GEÇKİL, Özkan Yetki̇n

    Introduction: In this study, changes in energy metabolism before and after treatment were compared in obstructive sleep apnea syndrome (OSAS) patients who received positive airway pressure therapy. Materials and Methods: Thirty-nine patients (22 male, 17 female) were admitted to study. Patients for PAP therapy who had moderate to severe in polysomnography were included. Values of energy metabolism were recorded during three days via metaboic holter device, before and after PAP therapy. Results: The mean age of the patients was 51.53 +/- 11.16 year. In 15 (38.46%) of the patients BPAP, and in 24 (61.54%) of the patients CPAP treatment started. Three days after using metabolic holter device: the total daily energy consumption of the patients was found to be 482,4 +/- 296.1 kcal/day before treatment and 524.5 +/- 343.1 kcal/day after treatment (p < 0.0001); patients' daily physical activity was 7867 +/- 3319 steps/day before treatment and 12.416 +/- 1451 steps/day after treatment, which was considered statistically significant (p < 0001); the total daily resting period of the patients was 7.90 +/- 1.36 hours/day before treatment and 7.44 +/- 1.42 hours/day after treatment, considered statistically significant (p < 0001); the total sleep duration of the patients was 5.50 +/- 1.88 hours/day before treatment and 5.87 +/- 1.20 hours/day after treatment, considered statistically significant (p < 0001). Conclusion: In our study, we found that daily physical activity and energy consumption increased with PAP treatment. With PAP treatment, obesity, diabetes and hypertension can be controlled. In our study, since PAP treatment was effective with effective sleep, the immobilization time was decreased and therefore the duration of daytime physical activity was prolonged. With these effects, patients' compliance with treatment increases. In conclusion, PAP treatment should be recommended in patients with moderate and severe OSAS.

  • CPAP compliance in patients with obstructive sleep apnea syndrome

    by Ozkan Yetkin, Erdogan Kunter, Hakan Gunen

    Obstructive sleep apnea syndrome (OSAS) is characterized by repeated cessations of breathing during sleep. Major symptoms of this disease are excessive daytime sleepiness, snoring, and witnessed apnea. Most of the patients are treated with CPAP. In this study, we aimed to evaluate the factors affecting adherence to the CPAP treatment. Seventy-one patients were enrolled to this study. Patients were divided into three groups according to CPAP usage. Group I consisted of patients who had never used CPAP, group II consisted of patients who had used CPAP occasionally, and group-III patients had used CPAP treatment regularly. Group-III patients had higher apnea–hypopnea index (AHI) than groups I and II (respectively, 56.6 ± 27.7, 26.3 ± 7.5, and 32.3 ± 7.06; p < 0.000 for both). Oxygen desaturation index was significantly higher in group-III patients comparing to groups I and II (44.6 ± 22.3, 15.9 ± 8.3, and 25.6 ± 9.5; p < 0.000 for all). Our findings have shown that only very severe patients use the CPAP device regularly (mean AHI 56.6 ± 27.7). Compliance to CPAP treatment seemed to be poor in patients with moderate to severe, AHI about 30, OSAS. Considering the well-established benefits of CPAP treatment in patients with true indications, patients should be encouraged to use CPAP regularly, and complications of OSAS should be keynoted.